Springer Nature
Browse
12957_2020_1792_MOESM2_ESM.tif (1.9 MB)

MOESM2 of Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis

Download (1.9 MB)
figure
posted on 2020-01-21, 05:11 authored by Jiahang Mo, Xiao Hu, Lihu Gu, Bangsheng Chen, Parikshit Khadaroo, Zefeng Shen, Lei Dong, Yuqi Lv, Marylin Chitumba, Jiequan Liu
Additional file 2: Figure S2. Sensitivity analysis of the long-term prognostic outcomes of anti-PD-1/PD-L1 therapy (Non-smoker vs. Smoker).

History

Usage metrics

    World Journal of Surgical Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC